Evaluation of Use of Diagnostic AI for Lung Cancer in Practice
- Conditions
- Lung Cancer
- Registration Number
- NCT03780582
- Lead Sponsor
- Ensemble Group Holdings, LLC
- Brief Summary
This study investigates ways of improving radiologists performance of the classification of CT-scans as cancerous or non-cancerous. Participants interact with an AI to classify CT-scans under three different conditions.
- Detailed Description
The three conditions are as follows: "probabilistic classification", where the radiologist diagnoses scans using an AI cancer likelihood score; "classification plus detection", where the radiologist see detecting lung nodules in addition to the AI's probabilistic classification score before making her own examination of the CT-scan; and "classification with delayed detection", where the radiologist identifies regions of interest independently of the AI and then sees the AI's detected ROIs.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 15
- The participant performs radiology screenings professionally
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Classification accuracy up to 4 months after initiation of evaluation of the test set This compares radiologists' classifications with the ground truth in the tested cases.
- Secondary Outcome Measures
Name Time Method detection concordance up to 4 months after initiation of evaluation of the test set Evaluation of concordance between radiologists in the tested cases in detection of lung nodules \> 4 mm
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Hong Kong
🇭🇰Hong Kong, Hong Kong
University of Hong Kong🇭🇰Hong Kong, Hong Kong